Clinical Trials Directory

Trials / Unknown

UnknownNCT02379104

ROTEM® Sigma Performance Evaluation - Method Comparison With Predicate Device and Reference Intervals

Status
Unknown
Phase
Study type
Observational
Enrollment
240 (estimated)
Sponsor
Tem Innovations GmbH · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

ROTEM® sigma is a new thromboelastometric coagulation analysis system. The new system is fully automated allowing for a simple and safe operation compared to its predecessor model ROTEM® delta. Method comparison of ROTEM® sigma with predecessor model ROTEM® delta) - confirmation of equality. Confirmation of reference intervals of the ROTEM® systems.

Detailed description

The main innovation of ROTEM® sigma is the development of a sample handler and a cartridge allowing for a of full automated test operation. As in ROTEM® delta four different tests can be run simultaneously on the four channels of the analyser. Whereas the tests in ROTEM® delta are performed manually by pipetting a blood sample and liquid system reagents, in ROTEM® sigma the reagents are contained in freeze dried pellet form in a cartridge. Test operation is performed by inserting a cartridge and attaching a blood sample to the analyser. The five available ROTEM® tests INTEM, EXTEM, FIBTEM, APTEM, and HEPTEM are contained in different combinations in two cartridge configurations: * Cartridge type 1 including INTEM, EXTEM, FIBTEM, APTEM * Cartridge type 2 including INTEM, EXTEM, FIBTEM, HEPTEM Aim of the study is the performance evaluation of the new ROTEM® sigma coagulation analyzer in comparison to the current ROTEM® delta thromboelastometry system. As a valid method comparison requires test results that cover the whole measurement range of the test system it is also necessary to include acute bleeding and emergency patients in the study. Only the inclusion of acute bleeding and emergency patients will produce strong pathologic test results allowing for a valid evaluation of the test system.

Conditions

Interventions

TypeNameDescription
DEVICEROTEM sigmaGroup Healthy Volunteers: a blood sample is tested with ROTEM sigma Group Patients with expected coagulopathy: a blood sample is tested with ROTEM sigma and ROTEM delta in parallel

Timeline

Start date
2017-10-01
Primary completion
2018-10-01
Completion
2018-12-01
First posted
2015-03-04
Last updated
2017-05-11

Locations

5 sites across 3 countries: United States, Austria, Switzerland

Source: ClinicalTrials.gov record NCT02379104. Inclusion in this directory is not an endorsement.